Yongyan Chen

4.8k total citations · 2 hit papers
57 papers, 3.7k citations indexed

About

Yongyan Chen is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Yongyan Chen has authored 57 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 17 papers in Epidemiology and 13 papers in Oncology. Recurrent topics in Yongyan Chen's work include Immune Cell Function and Interaction (35 papers), T-cell and B-cell Immunology (12 papers) and Hepatitis B Virus Studies (11 papers). Yongyan Chen is often cited by papers focused on Immune Cell Function and Interaction (35 papers), T-cell and B-cell Immunology (12 papers) and Hepatitis B Virus Studies (11 papers). Yongyan Chen collaborates with scholars based in China, United States and France. Yongyan Chen's co-authors include Zhigang Tian, Rui Sun, Haiming Wei, Min Cheng, Xiaodong Zheng, Weihua Xiao, Hui Peng, Jiacheng Bi, Bin Gao and Wenyong Wu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Yongyan Chen

56 papers receiving 3.7k citations

Hit Papers

Blockade of the checkpoint receptor TIGIT prevents NK... 2013 2026 2017 2021 2018 2013 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongyan Chen China 30 2.4k 1.3k 895 659 580 57 3.7k
Linda Hammerich Germany 24 1.3k 0.5× 666 0.5× 919 1.0× 653 1.0× 778 1.3× 51 2.9k
Takuya Miyagi Japan 34 1.8k 0.8× 774 0.6× 1.0k 1.2× 1.3k 2.0× 825 1.4× 104 4.0k
Satoshi Yamagiwa Japan 29 1.5k 0.6× 635 0.5× 576 0.6× 548 0.8× 654 1.1× 106 3.0k
Lifen Gao China 34 1.7k 0.7× 962 0.7× 778 0.9× 1.5k 2.2× 417 0.7× 105 3.7k
Hui Peng China 28 2.4k 1.0× 1.0k 0.8× 339 0.4× 736 1.1× 143 0.2× 104 3.7k
Takashi Suda Japan 15 1.6k 0.7× 576 0.4× 671 0.7× 2.1k 3.2× 395 0.7× 30 3.6k
Feng Shi China 21 619 0.3× 650 0.5× 404 0.5× 750 1.1× 353 0.6× 76 2.3k
Clifford S. Guy United States 26 1.5k 0.6× 540 0.4× 801 0.9× 1.7k 2.6× 146 0.3× 47 3.6k
Masaki Inoue Japan 33 1.1k 0.4× 768 0.6× 358 0.4× 1.1k 1.7× 167 0.3× 93 3.2k
Khalid S.A. Khabar Saudi Arabia 35 949 0.4× 508 0.4× 643 0.7× 1.7k 2.6× 554 1.0× 77 3.4k

Countries citing papers authored by Yongyan Chen

Since Specialization
Citations

This map shows the geographic impact of Yongyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongyan Chen more than expected).

Fields of papers citing papers by Yongyan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongyan Chen. The network helps show where Yongyan Chen may publish in the future.

Co-authorship network of co-authors of Yongyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yongyan Chen. A scholar is included among the top collaborators of Yongyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongyan Chen. Yongyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Haoyu, Zhe‐Xiong Lian, Haiming Wei, et al.. (2024). Hepatocyte-derived FGL1 accelerates liver metastasis and tumor growth by inhibiting CD8+ T and NK cells. JCI Insight. 9(13). 5 indexed citations
2.
Lu, Jiongdi, et al.. (2024). Unravelling the role of gut microbiota in acute pancreatitis: integrating Mendelian randomization with a nested case–control study. Frontiers in Microbiology. 15. 1401056–1401056. 2 indexed citations
3.
Chen, Yongyan, Xiaolei Hao, Ming Li, Zhigang Tian, & Min Cheng. (2023). UGRP1-modulated MARCO+ alveolar macrophages contribute to age-related lung fibrosis. Immunity & Ageing. 20(1). 14–14. 10 indexed citations
4.
Yu, Xiaoqi, Qiming Gong, Yongyan Chen, et al.. (2023). Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss. Gut. 73(5). 797–809. 22 indexed citations
5.
Yu, Xiaoqi, Dong Wei, Yongyan Chen, Donghua Zhang, & Xinxin Zhang. (2020). Retrospective detection of SARS-CoV-2 in hospitalized patients with influenza-like illness. Emerging Microbes & Infections. 9(1). 1470–1473. 6 indexed citations
6.
Chen, Yongyan & Zhigang Tian. (2020). Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer. Cellular and Molecular Immunology. 18(1). 57–72. 61 indexed citations
7.
Chen, Yongyan & Zhigang Tian. (2020). Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis. Frontiers in Immunology. 11. 1500–1500. 27 indexed citations
8.
Wu, Yuwei, Jinyu Wang, Xiaodong Zheng, et al.. (2020). Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model. Immunology Letters. 223. 33–43. 9 indexed citations
9.
Li, Fenglei, Yongyan Chen, Haiming Wei, et al.. (2019). CD4+ T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model. Frontiers in Immunology. 10. 927–927. 16 indexed citations
10.
Zong, Lu, Hui Peng, Cheng Sun, et al.. (2019). Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice. Nature Communications. 10(1). 221–221. 66 indexed citations
11.
Zhang, Qing, Jiacheng Bi, Xiaodong Zheng, et al.. (2018). Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nature Immunology. 19(7). 723–732. 813 indexed citations breakdown →
12.
Li, Tingting, Jian Wang, Yanshi Wang, et al.. (2016). Respiratory Influenza Virus Infection Induces Memory-like Liver NK Cells in Mice. The Journal of Immunology. 198(3). 1242–1252. 52 indexed citations
13.
Li, Shinan, Rui Sun, Yongyan Chen, Haiming Wei, & Zhigang Tian. (2015). TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression. Cancer Research. 75(6). 986–995. 59 indexed citations
14.
Xu, Cong‐Fei, Yongyan Chen, Jun Wang, et al.. (2015). Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice. Journal of Hepatology. 62(6). 1311–1318. 123 indexed citations
15.
Chen, Yongyan, et al.. (2015). Epimedium Flavonoids Ameliorate Neuropathological Changes and Increases IGF-1 Expression in C57BL/6 Mice Exposed to Cuprizone. Neurochemical Research. 40(3). 492–500. 16 indexed citations
16.
Bi, Jiacheng, Xiaodong Zheng, Yongyan Chen, et al.. (2014). TIGIT safeguards liver regeneration through regulating natural killer cell-hepatocyte crosstalk. Hepatology. 60(4). 1389–1398. 63 indexed citations
17.
Cheng, Min, Yongyan Chen, Weihua Xiao, Rui Sun, & Zhigang Tian. (2013). NK cell-based immunotherapy for malignant diseases. Cellular and Molecular Immunology. 10(3). 230–252. 507 indexed citations breakdown →
18.
Cheng, Min, Xiaodong Zheng, Yongyan Chen, et al.. (2012). A new reliable bioassay for determining the biological activity of human interleukin-12 by using human NK cell line NKG cells. International Immunopharmacology. 13(1). 109–113. 3 indexed citations
19.
Chen, Yongyan, et al.. (2009). Development, differentiation and immune recognition of natural killer cells.. Zhongguo mianyixue zazhi. 25(1). 31–34.
20.
Zhang, Weici, Yongyan Chen, Haiming Wei, et al.. (2008). Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts. Clinical Cancer Research. 14(20). 6432–6439. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026